Synthesis, characterisation and antioxidant properties of ferulate-based protic ionic liquids: Experimental and modelling approaches

Improving the sustainability of biodiesel by using imidazolium-based ionic liquid

Corrosion of biodiesel-filled fuel tanks has become a major problem in the use of biodiesel as a new green energy source. The ionic liquid 1-Hexyl-3-methylimidazolium bis(trifluoromethanesulfonyl)imide [C₁₀H₁₉N₂]⁺[C₂F₆NO₄S₂]⁻ was used to control corrosion of C-steel in non-edible biodiesel to resolve this problem. The anti-corrosion and antioxidant properties of the [C₁₀H₁₉N₂]⁺[C₂F₆NO₄S₂]⁻ were characterized using weight loss, electrochemical impedance spectroscopy, total acid number measurements beside SEM and EDX analysis. The findings show that [C₁₀H₁₉N₂]⁺[C₂F₆NO₄S₂]⁻ plays an important role in preventing C-steel corrosion in biodiesel with an efficiency close to 99 percent. The adsorption capability and antioxidant properties of [C₁₀H₁₉N₂]⁺[C₂F₆NO₄S₂]⁻ are the major contributors to the ionic liquid's anti-corrosion properties. We anticipate that this work will help to sustainable expand the use of biodiesel as a renewable energy source.

Freire CS, Silvestre AJD, Freire MG. The Role of Ionic Liquids in the Pharmaceutical Field: An Overview of Relevant Applications

Solubility, bioavailability, permeation, polymorphism, and stability concerns associated to solid-state pharmaceuticals demand for effective solutions. To overcome some of these drawbacks, ionic liquids (ILs) have been investigated as solvents, reagents, and anti-solvents in the synthesis and crystallization of active pharmaceutical ingredients (APIs), as solvents, co-solvents and emulsifiers in drug formulations, as pharmaceuticals (API-ILs) aiming liquid therapeutics, and in the development and/or improvement of drug-delivery-based systems. The present review focuses on the use of ILs in the pharmaceutical field, covering their multiple applications from pharmaceutical synthesis to drug delivery. The most relevant research conducted up to date is presented and discussed, together with a critical analysis of the most significant IL-based strategies in order to improve the performance of therapeutics and drug delivery systems.